本文へスキップ

相互作用

Cladribine + Tofacitinib

重症度: 併用禁忌

Cladribine and Tofacitinib: contraindicated interaction.

最終更新日

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

概要

Cladribine causes prolonged lymphopenia, and tofacitinib adds immunosuppression, markedly increasing the risk of serious infection. Oral cladribine labeling advises against combination with immunosuppressive therapies.

この相互作用をわかりやすく説明すると

Cladribine and Tofacitinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Cladribine belongs to Oncology; Tofacitinib belongs to Musculoskeletal.

エビデンスレベル: Moderate

なぜ起こるのか

Additive lymphocyte depletion and immunosuppression.

対処法

Do not combine; avoid tofacitinib during and after cladribine courses while lymphopenia persists. Select alternative therapy and monitor lymphocyte counts.

薬剤師に尋ねること

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、CladribineとTofacitinibの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

WebでPro+を14日間無料でお試し。カード登録不要。

よくある質問

Can I take Cladribine with Tofacitinib?

MediHelp rates the interaction as contraindicated. Cladribine and Tofacitinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Cladribine causes prolonged lymphopenia, and tofacitinib adds immunosuppression, markedly increasing the risk of serious infection. Oral cladribine labeling advises against combination with immunosuppressive therapies.

How serious is the interaction between Cladribine and Tofacitinib?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not combine; avoid tofacitinib during and after cladribine courses while lymphopenia persists. Select alternative therapy and monitor lymphocyte counts.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Upadacitinib, Abatacept. The full list is on the Tofacitinib page.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 相互作用

アプリを入手 ログイン